Proton pump inhibitors use and risk of chronic kidney disease and end-stage renal disease-Reference-Cited by-同舟云学术

Proton pump inhibitors use and risk of chronic kidney disease and end-stage renal disease

Published:2021-09 Issue:4 Volume:73 Page:
ISSN:2724-6051
Container-title:Minerva Urology and Nephrology
language:
Short-container-title:Minerva Urol Nephrol

Author:

VENGRUS Carolina S.,DELFINO Vinícius D.,BIGNARDI Paulo R.

Publisher

Edizioni Minerva Medica

Subject

General Medicine

Link

https://www.minervamedica.it/pdf.php?cod=R19Y2021N04A0462

Reference51 articles.

1. Pharmacology of proton pump inhibitors

2. 25 Years of Proton Pump Inhibitors: A Comprehensive Review

3. Proton pump inhibitors: actions and reactions

4. Proton Pump Inhibitors: Review of Emerging Concerns

5. Medicaid Integrity Program. Proton Pump Inhibitors : U. S. Food and Drug Administration - Approved Indications and Dosages for Use in Adults; 2013 [Internet]. Available from: https://www.cms.gov/Medicare-Medicaid-Coordination/Fraud-Prevention/Medicaid-Integrity-Education/Pharmacy-Education-Materials/Downloads/ppi-adult-dosingchart11-14.pdf [[cited 2021, Jun 22].

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multidisciplinary Consensus for Rationalizing the Use of Acid Suppressants in Children and Adults: CONFOR;Euroasian journal of hepato-gastroenterology;2024-06-12

2. Acute kidney injury associated with anti-PD-1 and anti-PD-L1 drugs: a meta-analysis of randomized clinical trials;Immunopharmacology and Immunotoxicology;2024-06-02

3. How could proton pump inhibitors de-prescription be managed in geriatric long-term care?;Therapies;2024-05

4. Non-indicated initiation of proton pump inhibitor and risk of adverse outcomes in patients with underlying chronic kidney disease: a nationwide, retrospective, cohort study;BMJ Open;2024-01

5. Safety analysis of co-administering tacrolimus and omeprazole in renal transplant recipients – A review;Biomedicine & Pharmacotherapy;2023-10